Moreover, our results are in line with observations in patients with relapsing-remitting MS that suggest an increase of circulating CD95−/loCD4+ and CD8+ T cells compared to healthy controls27,28. This evidence concerns the gene CD8A and relapsing-remitting multiple sclerosis.